Unlabelled: Background parenchymal enhancement (BPE), and the amount of fibroglandular tissue (FGT) assessed with MRI have been implicated as sensitive imaging biomarkers for breast cancer. The purpose of this study was to quantitatively assess breast parenchymal uptake (BPU) on F-FDG PET/CT as another valuable imaging biomarker and examine its correlation with BPE, FGT, and age.
Methods: This study included 129 patients with suspected breast cancer and normal imaging findings in one breast (BI-RADS 1), whose cases were retrospectively analyzed. All patients underwent prone F-FDG PET/CT and 3-T contrast-enhanced MRI of the breast. In all patients, interpreter 1 assessed BPU quantitatively using SUV Interpreters 1 and 2 assessed amount of FGT and BPE in the normal contralateral breast by subjective visual estimation, as recommended by BI-RADS. Interpreter 1 reassessed all cases and repeated the BPU measurements. Statistical tests were used to assess correlations between BPU, BPE, FGT, and age, as well as inter- and intrainterpreter agreement.
Results: BPU on F-FDG PET/CT varied among patients. The mean BPU SUV ± SD was 1.57 ± 0.6 for patients with minimal BPE, 1.93 ± 0.6 for mild BPE, 2.42 ± 0.5 for moderate BPE, and 1.45 ± 0.3 for marked BPE. There were significant (P < 0.001) moderate to strong correlations among BPU, BPE, and FGT. BPU directly correlated with both BPE and FGT on MRI. Patient age showed a moderate to strong indirect correlation with all 3 imaging-derived tissue biomarkers. The coefficient of variation for quantitative BPU measurements with SUV was 5.6%, indicating a high reproducibility. Interinterpreter and intrainterpreter agreement for BPE and FGT was almost perfect, with a κ-value of 0.860 and 0.822, respectively.
Conclusion: The results of our study demonstrate that BPU varied among patients. BPU directly correlated with both BPE and FGT on MRI, and BPU measurements were highly reproducible. Patient age showed a strong inverse correlation with all 3 imaging-derived tissue biomarkers. These findings indicate that BPU may serve as a sensitive imaging biomarker for breast cancer prediction, prognosis, and risk assessment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2967/jnumed.116.174904 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Increased background parenchymal enhancement on peri-menopausal breast magnetic resonance imaging.
Eur J Radiol Open
December 2024
Institute of Clinical Medicine, School of Medicine, Clinical Radiology, University of Eastern Finland, P.O. Box 1627, Kuopio Fl 70211, Finland.
Objectives: To examine the background parenchymal enhancement (BPE) levels in peri-menopausal breast MRI compared with pre- and post-menopausal breast MRI.
Methods: This study included 562 patients (55.8±12.
Intraindividual Comparison of Different Methods for Automated BPE Assessment at Breast MRI: A Call for Standardization.
Radiology
July 2024
From the Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Pauwelsstr 30, 52074 Aachen, Germany (G.M.F., F.K., S.T.A., L.H., M.B., T.H., T.L., S.N., C.K., D.T.); National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany (J.N.K.); Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, Germany (J.N.K.); Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany (J.N.K.); and Department of Medicine I, University Hospital Dresden, Dresden, Germany (J.N.K.).
Background The level of background parenchymal enhancement (BPE) at breast MRI provides predictive and prognostic information and can have diagnostic implications. However, there is a lack of standardization regarding BPE assessment. Purpose To investigate how well results of quantitative BPE assessment methods correlate among themselves and with assessments made by radiologists experienced in breast MRI.
View Article and Find Full Text PDFQuantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.
Eur Radiol
October 2024
Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Objectives: To compare the quantitative background parenchymal enhancement (BPE) in women with different lifetime risks and BRCA mutation status of breast cancer using screening MRI.
Materials And Methods: This study included screening MRI of 535 women divided into three groups based on lifetime risk: nonhigh-risk women, high-risk women without BRCA mutation, and BRCA1/2 mutation carriers. Six quantitative BPE measurements, including percent enhancement (PE) and signal enhancement ratio (SER), were calculated on DCE-MRI after segmentation of the whole breast and fibroglandular tissue (FGT).
How Does Diagnostic Accuracy Evolve with Increased Breast MRI Experience?
Tomography
November 2023
Breast Imaging Division, Medical Imaging Department, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.
Our institution is part of a provincial program providing annual breast MRI screenings to high-risk women. We assessed how MRI experience, background parenchymal enhancement (BPE), and the amount of fibroglandular tissue (FGT) affect the biopsy-proven predictive value (PPV3) and accuracy for detecting suspicious MRI findings. From all high-risk screening breast MRIs conducted between 1 July 2011 and 30 June 2020, we reviewed all BI-RADS 4/5 observations with pathological tissue diagnoses.
View Article and Find Full Text PDFGeneralizable attention U-Net for segmentation of fibroglandular tissue and background parenchymal enhancement in breast DCE-MRI.
Insights Imaging
November 2023
Diagnostic and interventional Radiology, University Hospital Zurich, University Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Objectives: Development of automated segmentation models enabling standardized volumetric quantification of fibroglandular tissue (FGT) from native volumes and background parenchymal enhancement (BPE) from subtraction volumes of dynamic contrast-enhanced breast MRI. Subsequent assessment of the developed models in the context of FGT and BPE Breast Imaging Reporting and Data System (BI-RADS)-compliant classification.
Methods: For the training and validation of attention U-Net models, data coming from a single 3.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!